UA103141C2 - Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases - Google Patents

Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases

Info

Publication number
UA103141C2
UA103141C2 UAA201212693A UAA201212693A UA103141C2 UA 103141 C2 UA103141 C2 UA 103141C2 UA A201212693 A UAA201212693 A UA A201212693A UA A201212693 A UAA201212693 A UA A201212693A UA 103141 C2 UA103141 C2 UA 103141C2
Authority
UA
Ukraine
Prior art keywords
hemotransfusions
cardio
markers
surgery
heart diseases
Prior art date
Application number
UAA201212693A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Янина Викторовна Ткаченко
Анна Михайловна Воробьева
Людмила Леонидовна Сидорик
Людмила Федоровна Яковенко
Илья Николаевич Емец
Original Assignee
Государственное Учреждение "Научно-Практический Медицинский Центр Детской Кардиологии И Кардиохирургии Министерства Здравоохранения Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Научно-Практический Медицинский Центр Детской Кардиологии И Кардиохирургии Министерства Здравоохранения Украины" filed Critical Государственное Учреждение "Научно-Практический Медицинский Центр Детской Кардиологии И Кардиохирургии Министерства Здравоохранения Украины"
Priority to UAA201212693A priority Critical patent/UA103141C2/en
Publication of UA103141C2 publication Critical patent/UA103141C2/en

Links

Abstract

The invention relates to use of anti-HSP60 antibodies of blood serum of donors as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases.
UAA201212693A 2012-11-07 2012-11-07 Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases UA103141C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201212693A UA103141C2 (en) 2012-11-07 2012-11-07 Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201212693A UA103141C2 (en) 2012-11-07 2012-11-07 Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases

Publications (1)

Publication Number Publication Date
UA103141C2 true UA103141C2 (en) 2013-09-10

Family

ID=52275647

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201212693A UA103141C2 (en) 2012-11-07 2012-11-07 Use of anti-hsp60 antibodies as markers of immune safety of hemotransfusions in cardio-surgery of congenital heart diseases

Country Status (1)

Country Link
UA (1) UA103141C2 (en)

Similar Documents

Publication Publication Date Title
WO2011113019A3 (en) Ctla4 proteins and their uses
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
WO2014145159A3 (en) Charge-engineered antibodies or compositions of penetration-enhanced targeting proteins and methods of use
MX2022000026A (en) Antibodies to tau.
PH12014502010A1 (en) Bispecific antibodies against human tweak and human il17 and uses thereof
WO2014189973A3 (en) Anti-transferrin receptor antibodies and methods of use
IN2015DN02032A (en)
UA110470C2 (en) Antidote of anticoagulant
EP2938616A4 (en) The present invention relates to process for the preparation of tofacitinib and intermediates thereof.
MX2015006859A (en) Anti-vegf antibodies and their uses.
IN2014DN08721A (en)
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
MX2014011186A (en) Method of enhancing efficacy of blood transfusions.
WO2013165921A3 (en) Therapeutic use of chardonnay seed products
EA201491357A1 (en) ANTI-LRP5 ANTIBODIES AND METHODS OF THEIR APPLICATION
HUE037613T2 (en) Anti-tlr4 antibodies and uses thereof
ZA201500228B (en) Ctla4 fusion proteins for the treatment of diabetes
IN2014DN06104A (en)
TN2013000388A1 (en) Anticoagulant antidotes
CO7160080A2 (en) Lipid compositions of racecadot
MX2014001766A (en) Neuregulin antibodies and uses thereof.
EA201500370A1 (en) PHARMACEUTICAL COMBINATIONS CONTAINING DOUBLE ANGIOPOETIN-2 / Dll4 BINDING AGENTS AND ANTI-VEGF-R AGENTS
MX361773B (en) Tlr3 binding agents.
WO2012095432A3 (en) Tlr3 binding agents